NASDAQ$MMSI
Merit Medical Systems Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Merit Medical reported Q4 2021 earnings with revenue up 7.9% and GAAP EPS increasing 32% year-over-year.
Merit Medical Systems, Inc. reported revenue of $278.5 million for Q4 2021, a 7.9% increase compared to Q4 2020. GAAP EPS increased 32% year-over-year to $0.36, and non-GAAP EPS increased 31% to $0.71. The company's performance exceeded the high end of its revenue and non-GAAP EPS guidance ranges.
- Q4 2021 revenue reached $278.5 million, up 7.9% reported and 8.4% on a constant currency, organic basis.
- GAAP EPS for Q4 2021 increased 32% year-over-year to $0.36.
- Non-GAAP EPS for Q4 2021 increased 31% year-over-year to $0.71.
- FY21 revenue was $1.075 billion, up 11.5% reported and 10.4% on a constant currency, organic basis.
Headline financials
Revenue & EPS history
Merit Medical · Revenue · Quarterly
$278M
Revenue by segment
Merit Medical · $8.27M total across 1 segment · Q4 2021
- Endoscopy$8.27M+4.2%100.0%
Forward guidance
Merit Medical provided financial guidance for the year ending December 31, 2022, projecting net revenue in the range of $1.117 billion to $1.140 billion and GAAP net income between $75.4 million and $84.0 million.
Tailwinds
- Net revenue in the range of $1.117 billion to $1.140 billion, representing an increase of approximately 4% to 6% year over year, as compared to net revenue of $1.075 billion for the twelve months ended December 31, 2021.
- Net revenue from the cardiovascular segment of between $1.083 billion and $1.106 billion, representing an increase of approximately 4% to 6% year-over-year as compared to net revenue of $1.043 billion for the twelve months ended December 31, 2021.
- Net revenue from the endoscopy segment of between $33.5 million and $34.1 million, representing an increase of approximately 6% to 8% year-over-year as compared to net revenue of $31.5 million for the twelve months ended December 31, 2021.
- GAAP net income in the range of $75.4 million to $84.0 million, or $1.30 to $1.45 per diluted share, compared to GAAP net income of $48.5 million, or $0.84 per diluted share, for the twelve months ended December 31, 2021.
- Non-GAAP net income in the range of $140.0 million to $148.7 million, or $2.41 to $2.56 per diluted share, compared to non-GAAP net income of $136.2 million, or $2.37 per diluted share, for the twelve months ended December 31, 2021.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
-0.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+1.8%
Avg return
30 days after
52%
34 / 65 earnings
Positive
+16.5%
Q3 2014
Best reaction
-31.4%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.2% | -6.8% | -2.8% | |
| Q4 2025 | -3.8% | -7.2% | -16.6% | |
| Q3 2025 | +5.1% | +4.9% | +4.3% | |
| Q1 2025 | -0.1% | -0.2% | +0.7% | |
| Q4 2024 | -1.5% | +1.0% | +1.9% | |
| Q3 2024 | +2.9% | +3.3% | +8.3% | |
| Q2 2024 | +4.0% | +5.0% | +13.4% | |
| Q1 2024 | +2.1% | +5.2% | +7.8% | |
| Q4 2023 | -5.3% | -4.9% | -5.9% | |
| Q3 2023 | +7.7% | +7.3% | +12.9% | |
| Q2 2023 | -9.6% | -8.3% | -16.4% | |
| Q1 2023 | +4.7% | +5.1% | +4.3% | |
| Q4 2022 | +2.8% | +1.3% | +3.7% | |
| Q3 2022 | +7.0% | +14.6% | +19.6% | |
| Q2 2022 | +6.0% | +10.6% | +10.0% | |
| Q1 2022 | -3.7% | -4.7% | -5.2% | |
| Q4 2021 | +8.4% | +9.3% | +5.0% | |
| Q3 2021 | -1.8% | -5.1% | -3.5% | |
| Q2 2021 | +7.6% | +3.9% | +10.1% | |
| Q1 2021 | -0.2% | +1.4% | -5.3% | |
| Q4 2020 | -1.8% | -0.4% | +1.9% | |
| Q3 2020 | +5.2% | +1.3% | +11.7% | |
| Q2 2020 | +4.3% | -1.9% | +11.6% | |
| Q1 2020 | +9.0% | +6.5% | +21.4% | |
| Q4 2019 | +0.4% | -9.5% | -17.0% | |
| Q3 2019 | -31.4% | -15.5% | -7.0% | |
| Q2 2019 | -24.7% | -26.2% | -37.2% | |
| Q1 2019 | -1.9% | -4.7% | -9.4% | |
| Q4 2018 | -4.3% | -2.1% | +1.6% | |
| Q3 2018 | -4.1% | -5.3% | -3.5% | |
| Q2 2018 | +2.8% | -3.1% | +3.3% | |
| Q1 2018 | +2.8% | +7.5% | +18.7% | |
| Q4 2017 | -2.1% | -5.1% | -3.3% | |
| Q3 2017 | -9.7% | -11.0% | +4.6% | |
| Q2 2017 | +4.8% | +5.5% | +4.6% | |
| Q1 2017 | +8.2% | +8.2% | +11.6% | |
| Q4 2016 | +5.9% | +4.8% | +0.0% | |
| Q3 2016 | -5.0% | -5.0% | +5.2% | |
| Q2 2016 | +6.1% | +6.7% | +6.5% | |
| Q1 2016 | +2.5% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | -27.3% | — | — | |
| Q2 2015 | +10.7% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | +7.7% | — | — | |
| Q3 2014 | +16.5% | — | — | |
| Q2 2014 | -14.4% | — | — | |
| Q1 2014 | -5.4% | — | — | |
| Q4 2013 | +1.2% | — | — | |
| Q3 2013 | +15.4% | — | — | |
| Q2 2013 | +7.6% | — | — | |
| Q1 2013 | -13.9% | — | — | |
| Q4 2012 | -14.7% | — | — | |
| Q3 2012 | -2.8% | — | — | |
| Q2 2012 | -0.5% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2011 | -0.7% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q1 2010 | -1.6% | — | — | |
| Q4 2009 | -1.6% | — | — | |
| Q3 2010 | -1.1% | — | — | |
| Q3 2011 | -1.1% | — | — | |
| Q2 2011 | +1.6% | — | — | |
| Q2 2010 | +1.6% | — | — | |
| Q4 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro